Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19-Reference-Cited by-同舟云学术

Comparison of In Vitro and In Vivo Inhibition Potencies of Fluvoxamine toward CYP2C19

Published:2003-05-01 Issue:5 Volume:31 Page:565-571
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Yao Caiping,Kunze Kent L.,Trager William F.,Kharasch Evan D.,Levy René H.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference33 articles.

1. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.;Adedoyin;Drug Metab Dispos,1987

2. High performance liquid chromatography with ultraviolet detection used for laboratory routine determination of fluvoxamine in human plasma

3. CDER (1999) Guidance for Industry: in vivo drug metabolism/drug interaction studies: study design, data analysis and recommendations for dosing and labeling.

4. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.;Crewe;Br J Clin Pharmacol,1992

5. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of CYP‐mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator;CPT: Pharmacometrics & Systems Pharmacology;2022-04-28

2. Reversible Mechanisms of Enzyme Inhibition and Resulting Clinical Significance;Methods in Molecular Biology;2021

3. A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine;Pharmaceutics;2020-12-08

4. (–)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes;Drug Metabolism and Disposition;2020-08-24

5. Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2;ACS Infectious Diseases;2020-03-04